FAHD2B
Oxaloacetate tautomerase FAHD2B, mitochondrial
Also known as: DKFZp434N062, FAH2B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6P2I3
- Gene
- FAHD2B
- Ensembl
- ENSG00000144199
- Chromosome
- 2
- Canonical length
- 314 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Enables oxaloacetate tautomerase activity. Involved in oxaloacetate metabolic process. Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
314 residues, UniProt reviewed canonical sequence.
>Q6P2I3|FAHD2B
1 MLVSGRRRLL TALLQAQKWP FQPSRDMRLV QFRAPHLVGP HLGLETGNGG GVINLNAFDP
61 TLPKTMTQFL EQGEATLSVA RRALAAQLPV LPWSEVTFLA PVTWPDKVVC VGMNYVDHCK
121 EQNVPVPKEP IIFSKFASSI VGPYDEVVLP PQSQEVDWEV ELAVVIGKKG KHIKATDAMA
181 HVAGFTVAHD VSARDWLTRR NGKQWLLGKT FDTFCPLGPA LVTKDSVADP HNLKICCRVN
241 GEVVQSSNTN QMVFKTEDLI AWVSQFVTFY PGDVILTGTP PGVGVFRKPP VFLKKGDEVQ
301 CEIEELGVII NKVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAHD2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- testis: 44 nTPM
- tongue: 43 nTPM
- epididymis: 36 nTPM
- midbrain: 30 nTPM
- basal ganglia: 30 nTPM
- spinal cord: 30 nTPM
Single-cell type
- late spermatids: 303 nCPM
- early spermatids: 259 nCPM
- late primary spermatocytes: 120 nCPM
- epididymal principal cells: 118 nCPM
- oocytes: 97 nCPM
- parietal cells: 35 nCPM
Immune cell
- NK-cell: 17 nTPM
- MAIT T-cell: 16 nTPM
- T-reg: 16 nTPM
- gdT-cell: 12 nTPM
- memory CD4 T-cell: 11 nTPM
- memory CD8 T-cell: 11 nTPM
Brain region
- white matter: 40 nTPM
- spinal cord: 32 nTPM
- cerebellum: 32 nTPM
- thalamus: 31 nTPM
- hypothalamus: 31 nTPM
- medulla oblongata: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.36
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- -0.24
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAHD2B as an antibody target. Whether an autoantibody or antibody against FAHD2B could matter depends on whether native FAHD2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAHD2B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAHD2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...